Immutep (IMMP) EBT Margin (2011 - 2017)

Immutep (IMMP) posted EBT Margin of 315.56% for Q2 2017, down 129.74% on a QoQ basis from 137.35% in Q1 2017, and up 67569.0% year-over-year from N/an in Q2 2016.

Immutep (IMMP) EBT Margin (2011 - 2017) Analysis & Trends

Immutep's EBT Margin history runs 5 years deep, the most recent figure standing at 315.56% for Q2 2017.

  • Quarterly EBT Margin rose 67569.0% year-over-year to 315.56% in Q2 2017, while the trailing twelve-month figure through Jun 2017 was 381.34% (up 11033.0% YoY) and the FY2025 annual result came in at 594.64%, down 3156.0% from the prior year.
  • EBT Margin was 315.56% for Q2 2017 at Immutep, down from 137.35% in the prior quarter.
  • Across five years, EBT Margin topped out at 103.46% in Q2 2014 and bottomed at 991.24% in Q2 2016.
  • A 4-year average of 431.48% and a median of 400.06% in 2015 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2015 — EBT Margin tumbled 58802 bps — and 2017, when it surged 67569 bps.
  • Immutep's EBT Margin stood at 103.46% in 2014, then tumbled by 568 bps to 484.56% in 2015, then slumped by 105 bps to 991.24% in 2016, then soared by 68 bps to 315.56% in 2017.
  • Business Quant data shows IMMP's EBT Margin at 315.56% in Q2 2017, 137.35% in Q1 2017, and 991.24% in Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 17.13%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 23.05%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 33.74%
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Immutep 569.08 Mn 569.08 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2017 -315.56%
Mar 31, 2017 -137.35%
Jun 30, 2016 -991.24%
Mar 31, 2016 -763.62%
Jun 30, 2015 -484.56%
Jun 30, 2014 103.46%
Jun 30, 2011 100.31%